PharmiWeb
Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
Paris (France) and Cambridge (Massachusetts, USA), July 11, 2024 – 07:00am CET – Biophytis SA (Euronext Growth Paris : ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology ...
18 hours ago